Old Web
English
Sign In
Acemap
>
authorDetail
>
Glenda C. Gobe
Glenda C. Gobe
Renal cell carcinoma
Medicine
Kidney disease
Internal medicine
Erythropoietin
4
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: an Australian population-based analysis
2018
Journal of Surgical Oncology
Thomas Ahn
Robert J. Ellis
Victoria White
Damien M Bolton
Michael Coory
Ian D Davis
Ross S. Francis
Graham G Giles
Glenda C. Gobe
Carmel M. Hawley
David W. Johnson
David J. T. Marco
Megan McStea
Rachel E. Neale
Elaine M. Pascoe
Simon Wood
Susan J. Jordan
Show All
Source
Cite
Save
Citations (9)
[Correspondence] Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease
2016
Pathology
Handoo Rhee
Keng Lim Ng
Brian Wan-Chi Tse
Mei-Chun Yeh
Pamela J. Russell
Colleen C. Nelson
Paul G. Thomas
Hemamali Samaratunga
Ian Vela
Glenda C. Gobe
Simon Wood
Show All
Source
Cite
Save
Citations (0)
Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease
2008
Glenda C. Gobe
David A. Vesey
Nigel C. Bennett
David W. Johnson
Show All
Source
Cite
Save
Citations (0)
The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy
2007
Jun Li
David A. Vesey
David W. Johnson
Glenda C. Gobe
Show All
Source
Cite
Save
Citations (0)
1